loader
Please Wait
Applying Filters...

Metrochem API Private Limited Metrochem API Private Limited

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Oteseconazole, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Oteseconazole

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    DIGITAL CONTENT

    PharmaCompass

    Veranova: A CDMO that manages complexity with confidence.

    Axplora- The partner of choice for complex APIs.

    2D Structure
    1. Also known as: 1340593-59-0, Vt-1161, Oteseconazole [usan], Vhh774w97n, Chembl3311228, (2r)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-[5-[4-(2,2,2-trifluoroethoxy)phenyl]pyridin-2-yl]propan-2-ol
    Molecular Formula
    C23H16F7N5O2
    Molecular Weight
    527.4  g/mol
    InChI Key
    IDUYJRXRDSPPRC-NRFANRHFSA-N
    FDA UNII
    VHH774W97N
    Oteseconazole has been used in trials studying the treatment of Tinea Pedis, Onychomycosis, Candidiasis, Vulvovaginal, and Recurrent Vulvovaginal Candidiasis.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    (2R)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-[5-[4-(2,2,2-trifluoroethoxy)phenyl]pyridin-2-yl]propan-2-ol
    2.1.2 InChI
    InChI=1S/C23H16F7N5O2/c24-16-4-7-18(19(25)9-16)21(36,11-35-13-32-33-34-35)23(29,30)20-8-3-15(10-31-20)14-1-5-17(6-2-14)37-12-22(26,27)28/h1-10,13,36H,11-12H2/t21-/m0/s1
    2.1.3 InChI Key
    IDUYJRXRDSPPRC-NRFANRHFSA-N
    2.1.4 Canonical SMILES
    C1=CC(=CC=C1C2=CN=C(C=C2)C(C(CN3C=NN=N3)(C4=C(C=C(C=C4)F)F)O)(F)F)OCC(F)(F)F
    2.1.5 Isomeric SMILES
    C1=CC(=CC=C1C2=CN=C(C=C2)C([C@](CN3C=NN=N3)(C4=C(C=C(C=C4)F)F)O)(F)F)OCC(F)(F)F
    2.2 Other Identifiers
    2.2.1 UNII
    VHH774W97N
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Vt-1161

    2.3.2 Depositor-Supplied Synonyms

    1. 1340593-59-0

    2. Vt-1161

    3. Oteseconazole [usan]

    4. Vhh774w97n

    5. Chembl3311228

    6. (2r)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-[5-[4-(2,2,2-trifluoroethoxy)phenyl]pyridin-2-yl]propan-2-ol

    7. (r)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1h-tetrazol-1-yl)-1-(5-(4-(2,2,2-trifluoroethoxy)phenyl)pyridin-2-yl)propan-2-ol

    8. 2-pyridineethanol, Alpha-(2,4-difluorophenyl)-beta,beta-difluoro-alpha-(1h-tetrazol-1-ylmethyl)-5-(4-(2,2,2-trifluoroethoxy)phenyl)-, (alphar)-

    9. 2-pyridineethanol, Alpha-(2,4-difluorophenyl)-beta,beta-difluoro-alpha-(1h-tetrazol-1-ylmethyl)-5-[4-(2,2,2-trifluoroethoxy)phenyl]-, (alphar)-

    10. Vivjoa

    11. Oteseconazole [inn]

    12. Oteseconazole (usan/inn)

    13. Unii-vhh774w97n

    14. Oteseconazole, (+)-

    15. Oteseconazole [who-dd]

    16. Schembl17113021

    17. Chebi:188153

    18. Bdbm50046187

    19. Who 10138

    20. Db13055

    21. Sb17420

    22. Vt-1161vt-1161

    23. Hy-17643

    24. Cs-0016914

    25. D11785

    26. D87154

    27. Q27291837

    28. (2r)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1h-tetrazol-1-yl)-1-{5-[4-(2,2,2-trifluoroethoxy)phenyl]pyridin-2-yl}propan-2-ol

    29. (alphar)-alpha-(2,4-difluorophenyl)-beta,beta-difluoro-alpha-(1h-tetrazol-1-ylmethyl)-5-[4-(2,2,2-trifluoroethoxy)phenyl]-2-pyridineethanol

    2.4 Create Date
    2014-09-01
    3 Chemical and Physical Properties
    Molecular Weight 527.4 g/mol
    Molecular Formula C23H16F7N5O2
    XLogP34.2
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count13
    Rotatable Bond Count8
    Exact Mass527.11922190 g/mol
    Monoisotopic Mass527.11922190 g/mol
    Topological Polar Surface Area86 Ų
    Heavy Atom Count37
    Formal Charge0
    Complexity743
    Isotope Atom Count0
    Defined Atom Stereocenter Count1
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Drug and Medication Information
    4.1 Drug Indication

    Treatment of vulvovaginal candidiasis

    5 Pharmacology and Biochemistry
    5.1 ATC Code

    J - Antiinfectives for systemic use

    J02 - Antimycotics for systemic use

    J02A - Antimycotics for systemic use

    J02AC - Triazole and tetrazole derivatives

    J02AC06 - Oteseconazole

    Post Enquiry
    POST ENQUIRY